1996
DOI: 10.1074/jbc.271.48.30631
|View full text |Cite
|
Sign up to set email alerts
|

Annexin II Modulates Volume-activated Chloride Currents in Vascular Endothelial Cells

Abstract: The membrane-associated, microfilament-binding protein annexin II is abundantly expressed in endothelial cells from calf pulmonary artery (CPAE cells). We have analyzed its role in the regulation of volume-activated chloride currents (I Cl, vol ) by loading the cells via the patch pipette with a peptide comprising the N-terminal 14 residues of annexin II. This sequence harbors the binding site for the intracellular annexin II ligand, p11, and the peptide interferes with the annexin II-p11 complex formation. Lo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
54
0

Year Published

1999
1999
2012
2012

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(57 citation statements)
references
References 33 publications
3
54
0
Order By: Relevance
“…Perturbing the F-actin microfilament system with phalloidin or cytochalasin B did not interfere with the swelling-induced activation of VRACs in endothelial cells ). However, we have recently provided evidence that annexin II, a plasma membrane-associated, actin filament-binding protein plays a functional role in the activation of VRACs in CPAE cells, suggesting a role for the subplasma membrane cytoskeleton (Nilius et al 1996b). Whether the Rho-Rho kinase effects on VRACs are exerted via the subplasma membrane cytoskeleton remains to be investigated.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Perturbing the F-actin microfilament system with phalloidin or cytochalasin B did not interfere with the swelling-induced activation of VRACs in endothelial cells ). However, we have recently provided evidence that annexin II, a plasma membrane-associated, actin filament-binding protein plays a functional role in the activation of VRACs in CPAE cells, suggesting a role for the subplasma membrane cytoskeleton (Nilius et al 1996b). Whether the Rho-Rho kinase effects on VRACs are exerted via the subplasma membrane cytoskeleton remains to be investigated.…”
Section: Discussionmentioning
confidence: 99%
“…inhibitory effect of Y_27632, we repeatedly activated ICl,swell in the presence of the blocker. Repetitive stimulation of control CPAE cells with HTS activates ICl,swell without significant run-down (Nilius et al 1996b;see also Figs 2A and 4D). However, in the continuous presence of 10 ìÒ Y_27632, we observed a slow but substantial decay of current responses, which could not be attributed to a reduced cell swelling (Fig.…”
Section: Modulation Of Vracs By Y_27632 An Inhibitor Of Rho Kinasementioning
confidence: 99%
“…For example, annexin IV inhibits calmodulin-sensitive Cl − channels (37,38) as well as Ca 2+ -activated Cl − channels (39). In endothelial cells the annexin II-S100A10 complex might be involved in regulation of the swelling-activated Cl − channel (40) and cystic fibrosis transmembrane conductance regulator (41).…”
Section: Discussionmentioning
confidence: 99%
“…These different forms seem to be present in distinct subcellular compartments; AnxA2 monomer is mainly cytosolic (49 -51), whereas the heterodimer has been described in the nucleus (52)(53)(54) and the heterotetramer is associated with the plasma membrane (55). The AnxA2 heterotetramer is the most abundant form of the protein, representing 90 -95% of the total AnxA2 in endothelial, epithelial, and Madin-Darby canine kidney cells (34,56). The p11 light chain regulates many of the activities of AnxA2 and confers to the heterotetramer biochemical properties distinct from those of the monomer (49,57,58).…”
Section: Discussionmentioning
confidence: 99%